Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.4342 USD
−169.93 M USD
25.38 M USD
75.94 M
About Invivyd, Inc.
Sector
Industry
CEO
William E. Duke
Website
Headquarters
Waltham
Founded
2020
FIGI
BBG00W4ML039
Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.
IVVD Doubled on Clinical Trial ResultsInvivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. Earnings in 48 days. Avg 30D Vol at 24.67M Current Vol at 74.70M
Can this break and retest $2.35? If it does analyst have targets as high as $10.
Invivyd Inc. Stock Quote | Chart & Forecast SummaryKey Indicators On Trade Set Up In General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Notes On Session
# Invivyd Inc. Stock Quote
- Double Formation
* (Neckline) | Completed Survey & Entry Bias
* 012345 | Wave Count Configuration | Subdivision 1
- Triple Formation
* Retracement Numbere
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of IVVD is 0.4883 USD — it has decreased by −2.11% in the past 24 hours. Watch Invivyd, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Invivyd, Inc. stocks are traded under the ticker IVVD.
IVVD stock has fallen by −6.66% compared to the previous week, the month change is a −36.72% fall, over the last year Invivyd, Inc. has showed a −82.24% decrease.
We've gathered analysts' opinions on Invivyd, Inc. future price: according to them, IVVD price has a max estimate of 10.00 USD and a min estimate of 0.80 USD. Watch IVVD chart and read a more detailed Invivyd, Inc. stock forecast: see what analysts think of Invivyd, Inc. and suggest that you do with its stocks.
IVVD reached its all-time high on Nov 30, 2021 with the price of 78.8200 USD, and its all-time low was 0.3546 USD and was reached on Jan 30, 2025. View more price dynamics on IVVD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IVVD stock is 7.59% volatile and has beta coefficient of 1.72. Track Invivyd, Inc. stock price on the chart and check out the list of the most volatile stocks — is Invivyd, Inc. there?
Today Invivyd, Inc. has the market capitalization of 61.66 M, it has decreased by −5.29% over the last week.
Yes, you can track Invivyd, Inc. financials in yearly and quarterly reports right on TradingView.
Invivyd, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
IVVD earnings for the last quarter are −0.15 USD per share, whereas the estimation was −0.20 USD resulting in a 25.00% surprise. The estimated earnings for the next quarter are −0.03 USD per share. See more details about Invivyd, Inc. earnings.
Invivyd, Inc. revenue for the last quarter amounts to 13.80 M USD, despite the estimated figure of 13.57 M USD. In the next quarter, revenue is expected to reach 34.45 M USD.
IVVD net income for the last quarter is −18.44 M USD, while the quarter before that showed −60.74 M USD of net income which accounts for 69.64% change. Track more Invivyd, Inc. financial stats to get the full picture.
No, IVVD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 16, 2025, the company has 99 employees. See our rating of the largest employees — is Invivyd, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Invivyd, Inc. EBITDA is −173.76 M USD, and current EBITDA margin is −684.54%. See more stats in Invivyd, Inc. financial statements.
Like other stocks, IVVD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Invivyd, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Invivyd, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Invivyd, Inc. stock shows the sell signal. See more of Invivyd, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.